From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

BARDA to Open New BAA for CBRN Medical Countermeasures

by Stephanie Lizotte
February 23, 2012

Biomedical Advanced Research and Development Authority (BARDA) will release a new Broad Agency Announcment (BAA) on 4 March, 2012 for Advanced Research and Development of CBRN Medical Countermeasures.

The purpose of the BAA is to solicit and fund proposals that focus on the following research areas in order to advance the knowledge and scientific understanding of selected candidates’ countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS):

  • Vaccines Development
  • Antitoxins and Therapeutics
  • Antimicrobials and Antivirals
  • Radiological and Nuclear Agent Countermeasures
  • Chemical Agent Countermeasures
  • Diagnostics

BARDA, under the Department of Health and Human Services, encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).

The solicitation number is BARDA-CBRN-BAA-12-100-SOL-00011 with details available here. It is anticipated that a pre-proposal conference will be held in late April, 2012 in the Washington D.C. area and possibly a opportuntity for organizations to participate by phone. Global Biodefense will publish further details as they become available.

From Our Partners
Tags: AntimicrobialsAntitoxinsAntiviralsASPRBAABARDAHHSPOC DiagnosticsStrategic National StockpileVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC